Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09CAI
|
|||
| Former ID |
DNC014580
|
|||
| Drug Name |
TAUTOMYCIN
|
|||
| Synonyms |
Tautomycin; AC1L99OL; CHEBI:9414; CHEMBL505512; CTK8E8541; 109946-35-2; Tautomycin from Streptomyces spiroverticillatus; SCHEMBL83891; DNC014580; BDBM50366883; RT-015883; C05372; J-002353; [(1R,2R,3R,6S,7S,10R)-10-[(2S,3S,6R,8S,9R)-3,9-dimethyl-8-[(3S)-3-methyl-4-oxo-pentyl]-1,7-dioxaspiro[5.5]undecan-2-yl]-3,7-dihydroxy-1-isopropyl-2-methoxy-6-methyl-5-oxo-undecyl] (3R)-3-hydroxy-3-(4-methyl-2,5-dioxo-3-furyl)propanoate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C41H66O13
|
|||
| Canonical SMILES |
CC1CCC2(CCC(C(O2)C(C)CCC(C(C)C(=O)CC(C(C(C(C)C)OC(=O)CC(C3=C(C(=O)OC3=O)C)O)OC)O)O)C)OC1CCC(C)C(=O)C
|
|||
| InChI |
1S/C41H66O13/c1-21(2)36(51-34(47)20-31(45)35-27(8)39(48)52-40(35)49)38(50-10)32(46)19-30(44)26(7)29(43)13-11-24(5)37-25(6)16-18-41(54-37)17-15-23(4)33(53-41)14-12-22(3)28(9)42/h21-26,29,31-33,36-38,43,45-46H,11-20H2,1-10H3/t22-,23+,24+,25-,26-,29-,31+,32+,33-,36+,37-,38+,41+/m0/s1
|
|||
| InChIKey |
RFCWHQNNCOJYTR-IRCAEPKSSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:9414
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serine/threonine PP1-alpha (PPP1CA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem. 2002 Mar 14;45(6):1151-75. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.